Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Vivani Medical, Inc. (EYES)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/15/2023 |
8-K
| Quarterly results|
Docs:
|
"Vivani Medical, Inc. Guaranteed Adherence. Better Outcomes. Nasdaq: VANI May 15, 2023 www.vivani.com",
"VIVANI MEDICAL, INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets March 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 38,073 $ 45,076 Prepaid expenses and other current assets 2,611 2,452 Total current assets 40,684 47,528 Property and equipment, net 1,111 1,182 Right-of-use assets 1,148 779 Restricted cash 1,366 1,366 Deposits and other assets 271 275 Total assets $ 44,580 $ 51,130 LIABILITIE S AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 746 $ 1,177 Accrued expenses 2,114 2,358 Litigation accrual 1,675 1,675 Accrued compensation expense 415 657 Current operating lease liabilities 913 955 Total current liabilities 5,863 6,822 Long term operating lease liabilities 349 — Total liabilities 6,212 6,822 Commitments and contingencie..." |
|
| 11/14/2022 |
8-K
| Quarterly results|
Docs:
|
"VIVANI MEDICAL, INC. AND SUBSIDIARY Condensed Consolidated Balance Sheets September 30, December 31, 2022 2021 ASSETS Current assets: Cash and cash equivalents $ 51,684 $ 2,178 Prepaid expenses and other current assets 2,779 291 Total current assets 54,463 2,469 Property and equipment, net 1,250 1,173 Right-of-use assets 1,050 1,611 Deposits and other assets 259 200 Total assets $ 57,022 $ 5,453 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,969 $ 281 Accrued expenses 1,853 895 Accrued compensation expense 555 — Current operating lease liabilities 1,243 910 Total current liabilities 5,620 2,086 Long term operating lease liabilities 42 902 Total liabilities 5,662 2,988 Commitments and contingencies Stockholders’ equity: Preferred stock, no par value, 10,000 ..." |
|
| 11/14/2019 |
8-K
| Quarterly results |
| 08/06/2019 |
8-K
| Quarterly results |
| 05/15/2019 |
8-K
| Quarterly results |
| 03/13/2019 |
8-K
| Quarterly results |
| 11/07/2018 |
8-K
| Quarterly results |
| 08/08/2018 |
8-K
| Quarterly results |
| 05/04/2017 |
8-K
| Form 8-K - Current report |
| 11/04/2016 |
8-K
| Form 8-K - Current report |
| 08/01/2016 |
8-K
| Form 8-K - Current report |
| 04/28/2016 |
8-K
| Quarterly results |
| 10/29/2015 |
8-K
| Quarterly results |
| 08/04/2015 |
8-K
| Quarterly results |
| 05/14/2015 |
8-K
| Quarterly results |
|
|